About Menter Dermatology Research Institute (MDRI)
Menter Dermatology Research Institute was established to address the ongoing need for new, clinically safe and effective treatments for physically and psychologically debilitating skin diseases. Although we have a significant and long standing interest in psoriasis research and treatment, we are pleased to be offering clinical studies for a wide range of cutaneous manifestations such as atopic dermatitis, hidradenitis suppurativa, skin cancers, and pyoderma gangrenosum inter alia.
After years of dedication to psoriasis research, including involvement in over 150 clinical research trials in past 35 years, Dr. Alan Menter opened a specialty Research Center in 2011. Menter Dermatology Research Institute (MDRI) was established to combine Dr. Menter’s interest in both clinical Dermatology and Research locally, nationally, and internationally. For years, Dr. Menter has been involved in clinical research trials for psoriasis and considered a leader and innovator in psoriasis treatment. His dedication has put him at the frontier of investigational therapies in psoriasis and he has now expanded his research interest through clinical trials in a host of other dermatologic disease processes.
MDRI has a full time staff which includes a Director of Operations, Director of Finance and Regulatory Affairs, Clinical Research Coordinators, Data Entry Specialist, and a full time MD Clinical Research Fellow, all dedicated to clinical and investigative research and patient care, in full compliance with FDA regulations.
For further information regarding any available research studies, please review our "Current Studies” or contact us toll free at (855) 554-6374.